Diagnosis and management of adult coeliac disease: Guidelines from the British society of gastroenterology

Gut

Volumn 63, Issue 8, 2014, Pages 1210-1228

  Ludvigsson, Jonas F ^a,b   Bai, Julio C ^c   Biagi, Federico ^d   Card, Timothy R ^e   Ciacci, Carolina ^f   Ciclitira, Paul J ^g   Green, Peter H R ^h   Hadjivassiliou, Marios ⁱ   Holdoway, Anne ^j   Van Heel, David A ^k   Kaukinen, Katri ^l,m,n   Leffler, Daniel A ^o   Leonard, Jonathan N ^p   Lundin, Knut E A ^q   McGough, Norma ^r   Davidson, Mike ^r   Murray, Joseph A ^s   Swift, Gillian L ^t   Walker, Marjorie M ^u   Zingone, Fabiana ^f   Sanders, David S ^v   more..

^a KAROLINSKA INSTITUTE   (Sweden)

^b ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSIDAD DEL SALVADOR   (Argentina)

^d UNIVERSITY OF PAVIA   (Italy)

^e UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^f UNIVERSITY OF SALERNO   (Italy)

^g ST THOMAS HOSPITAL   (United Kingdom)

^h Och Spine at New York Presbyterian Hospitals   (United States)

ⁱ ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^j BRITISH DIETETIC ASSOCIATION   (United Kingdom)

^k QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^l TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^m TAMPERE UNIVERSITY HOSPITAL   (Finland)

ⁿ SEINÄJOKI CENTRAL HOSPITAL   (Finland)

^o HARVARD MEDICAL SCHOOL   (United States)

^p ST MARY S HOSPITAL   (United Kingdom)

^q OSLO UNIVERSITY HOSPITAL   (Norway)

^r Policy Research and Campaigns   (United Kingdom)

^s MAYO CLINIC   (United States)

^t LLANDOUGH HOSPITAL   (United Kingdom)

^u UNIVERSITY OF NEWCASTLE   (Australia)

^v UNIVERSITY OF SHEFFIELD   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BUDESONIDE; CLADRIBINE; CYCLOSPORIN; HLA ANTIGEN; STEROID; THIOGUANINE DERIVATIVE;

ADULT; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; B CELL LYMPHOMA; CALCIUM INTAKE; CELIAC DISEASE; DERMATITIS HERPETIFORMIS; DIET SUPPLEMENTATION; DISEASE CLASSIFICATION; DUODENUM BIOPSY; DUODENUM DISEASE; DUODENUM MUCOSA; EVIDENCE BASED MEDICINE; FOLLOW UP; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL SYMPTOM; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; GLUTEN FREE DIET; HISTOPATHOLOGY; HLA TYPING; HUMAN; INTESTINE VILLUS ATROPHY; LYMPHOCYTIC DUODENOSIS; MEDICAL SOCIETY; NUTRITIONAL COUNSELING; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PATIENT SAFETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; SERODIAGNOSIS; SUPPORT GROUP; TREATMENT RESPONSE; UNITED KINGDOM;

COELIAC DISEASE; GLUTEN; GLUTEN FREE DIET; SMALL BOWEL DISEASE;

ADULT; BIOPSY; CELIAC DISEASE; DIET, GLUTEN-FREE; DUODENUM; ENDOSCOPY, GASTROINTESTINAL; GLIADIN; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOGLOBULIN A; TRANSGLUTAMINASES;

EID: 84904060668     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2013-306578     Document Type: Article

References (307)

1. Husby S, Koletzko S, Korponay-Szabo IR, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr 2012;54:136-60.
2. Ciclitira P, Dewar DH, McLaughlin SD, et al. The Management of Adults with Coeliac Disease. London: British Society of Gastroenterology, 2010.
3. NICE. Coeliac Disease Recognition and Assessment of Celiac Disease. London, 2009.
4. Bai JC, Fried M, Corazza GR, et al. World gastroenterology organisation global guidelines on celiac disease. J Clin Gastroenterol 2013;47:121-6.
5. Rubio- Tapia A, Hill ID, Kelly CP, et al. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol 2013;108:656-76; quiz 77.
6. National Institutes of Health Consensus Development Conference Statement on Celiac Disease, June 28-30, 2004. Gastroenterology 2005;128(Suppl 1):1-9.
7. Ludvigsson JF, Leffler DA, Bai JC, et al. The Oslo definitions for coeliac disease and related terms. Gut 2013;62:43-52.
8. Fasano A, Catassi C. Current approaches to diagnosis and treatment of celiac disease: An evolving spectrum. Gastroenterology 2001;120:636-51. (Pubitemid 32171637)
9. Farrell RJ, Kelly CP. Celiac sprue. N Engl J Med 2002;346:180-8. (Pubitemid 34438885)
10. Green PH, Cellier C. Celiac disease. N Engl J Med 2007;357:1731-43.
11. Green PH, Jabri B. Coeliac disease. Lancet 2003;362:383-91. (Pubitemid 36945070)
12. Di Sabatino A, Corazza GR. Coeliac disease. Lancet 2009;373:1480-93.
13. Schuppan D, Junker Y, Barisani D. Celiac disease: from pathogenesis to novel therapies. Gastroenterology 2009;137:1912-33.
14. van Heel DA, West J. Recent advances in coeliac disease. Gut 2006;55:1037-46. (Pubitemid 43962618)
15. Leffler D. Celiac disease diagnosis and management: A 46-year-old woman with anemia. JAMA 2011;306:1582-92.
16. Walker MM, Murray JA. An update in the diagnosis of coeliac disease. Histopathology 2011;59:166-79.
17. Haines ML, Anderson RP, Gibson PR. Systematic review: The evidence base for long- Term management of coeliac disease. Aliment Pharmacol Ther 2008;28:1042-66.
18. Oxford Centre for Evidence-based Medicine-Levels of Evidence. Oxford: Centre for Evidence-based Medicine, Oxford University, 2009.
19. Dicke WK, Weijers HA, Van De Kamer JH. Coeliac disease. II. The presence in wheat of a factor having a deleterious effect in cases of coeliac disease. Acta Paediatr 1953;42:34-42.
20. Taylor KB, Truelove SC, Thomson DL, et al. An immunological study of coeliac disease and idiopathic steatorrhoea. Serological reactions to gluten and milk proteins. Br Med J 1961;2:1727-31.
21. Cooke WT, Fone DJ, Cox EV, et al. Adult coeliac disease. Gut 1963;4:279-91.
22. Dube C, Rostom A, Sy R, et al. The prevalence of celiac disease in average-risk and at-risk Western European populations: A systematic review. Gastroenterology 2005;128:57-67.
23. Corazza GR, Andreani ML, Biagi F, et al. The smaller size of the 'coeliac iceberg' in adults. Scand J Gastroenterol 1997;32:917-19. (Pubitemid 27382037)
24. Maki M, Mustalahti K, Kokkonen J, et al. Prevalence of celiac disease among children in Finland. N Engl J Med 2003;348:2517-24. (Pubitemid 36706539)
25. Mustalahti K, Catassi C, Reunanen A, et al. The prevalence of celiac disease in Europe: results of a centralized, international mass screening project. Ann Med 2010;42:587-95.
26. Bingley PJ, Williams AJ, Norcross AJ, et al. Undiagnosed coeliac disease at age seven: population based prospective birth cohort study. BMJ 2004;328:322-3. (Pubitemid 38197849)
27. West J, Logan RF, Hill PG, et al. Seroprevalence, correlates, and characteristics of undetected coeliac disease in England. Gut 2003;52:960-5. (Pubitemid 36765286)
28. Rubio- Tapia A, Ludvigsson JF, Brantner TL, et al. The prevalence of celiac disease in the United States. Am J Gastroenterol 2012;107:1538-44; quiz 37, 45.
29. Murray JA, Van Dyke C, Plevak MF, et al. Trends in the identification and clinical features of celiac disease in a North American community, 1950-2001. Clin Gastroenterol Hepatol 2003;1:19-27. (Pubitemid 37254468)
30. Fasano A, Berti I, Gerarduzzi T, et al. Prevalence of celiac disease in at-risk and not- At-risk groups in the United States: A large multicenter study. Arch Intern Med 2003;163:286-92. (Pubitemid 36183856)
31. Rampertab SD, Pooran N, Brar P, et al. Trends in the presentation of celiac disease. Am J Med 2006;119:3559-14.
32. Bergamaschi G, Markopoulos K, Albertini R, et al. Anemia of chronic disease and defective erythropoietin production in patients with celiac disease. Haematologica 2008;93:1785-91.
33. Sanders DS, Carter MJ, Hurlstone DP, et al. Association of adult coeliac disease with irritable bowel syndrome: A case-control study in patients fulfilling ROME II criteria referred to secondary care. Lancet 2001;358:1504-8. (Pubitemid 33055702)
34. Hadjivassiliou M, Gibson A, Davies-Jones GA, et al. Does cryptic gluten sensitivity play a part in neurological illness?. Lancet 1996;347:369-71. (Pubitemid 26046106)
35. Ludvigsson JF, Olsson T, Ekbom A, et al. A population-based study of coeliac disease, neurodegenerative and neuroinflammatory diseases. Aliment Pharmacol Ther 2007;25:1317-27. (Pubitemid 46763464)
36. Hadjivassiliou M, Grunewald R, Sharrack B, et al. Gluten ataxia in perspective: epidemiology, genetic susceptibility and clinical characteristics. Brain 2003;126:685-91. (Pubitemid 36240868)
37. Ludvigsson JF, Reutfors J, Osby U, et al. Coeliac disease and risk of mood disorders- A general population-based cohort study. J Affect Disord 2007;99:117-26. (Pubitemid 46275025)
38. Groll A, Candy DC, Preece MA, et al. Short stature as the primary manifestation of coeliac disease. Lancet 1980;2:1097-9. (Pubitemid 11240731)
39. Olmos M, Antelo M, Vazquez H, et al. Systematic review and meta- Analysis of observational studies on the prevalence of fractures in coeliac disease. Dig Liver Dis 2008;40:46-53. (Pubitemid 350246392)
40. Ludvigsson JF, Elfstrom P, Broome U, et al.Celiac disease and risk of liver disease: A general population-based study. Clin Gastroenterol Hepatol 2007;5:63-69.
41. Ludvigsson JF, Montgomery SM, Ekbom A. Celiac disease and risk of adverse fetal outcome: A population-based cohort study. Gastroenterology 2005;129: 454-63. (Pubitemid 41096633)
42. West J, Logan RF, Smith CJ, et al. Malignancy and mortality in people with coeliac disease: population based cohort study. BMJ 2004;329:716-19.
43. Meeuwisse GW. Round table discussion. Diagnostic criteria in coeliac disease. Acta Paediatr 1970;59:461-63.
44. McNeish AS, Harms HK, Rey J, et al. The diagnosis of coeliac disease. A commentary on the current practices of members of the European Society for Paediatric Gastroenterology and Nutrition (ESPGAN). Arch Dis Child 1979;54:783-6. (Pubitemid 10232376)
45. Revised Criteria for Diagnosis of Coeliac Disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition. Arch Dis Child 1990;65:909-11.
46. Sollid LM, Lie BA. Celiac disease genetics: current concepts and practical applications. Clin Gastroenterol Hepatol 2005;3:843-51. (Pubitemid 41222309)
47. Welander A, Tjernberg AR, Montgomery SM, et al. Infectious disease and risk of later celiac disease in childhood. Pediatrics 2010;125:530-6.
48. Greco L, Auricchio S, Mayer M, et al. Case control study on nutritional risk factors in celiac disease. J Pediatr Gastroenterol Nutr 1988;7:395-9.
49. Ivarsson A, Persson LA, Nystrom L, et al. Epidemic of coeliac disease in Swedish children. Acta Paediatr 2000;89:165-71. (Pubitemid 30339587)
50. Stene LC, Honeyman MC, Hoffenberg EJ, et al. Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: A longitudinal study. Am J Gastroenterol 2006;101:2333-40. (Pubitemid 44477562)
51. Riddle MS, Murray JA, Porter CK. The incidence and risk of celiac disease in a healthy US adult population. Am J Gastroenterol 2012;107:1248-55.
52. Jabri B, Sollid LM. Tissue-mediated control of immunopathology in coeliac disease. Nat Rev Immunol 2009;9:858-70.
53. Rubio- Tapia A, Van Dyke CT, Lahr BD, et al. Predictors of family risk for celiac disease: A population-based study. Clin Gastroenterol Hepatol 2008;6:983-7.
54. Greco L, Romino R, Coto I, et al. The first large population based twin study of coeliac disease. Gut 2002;50:624-8. (Pubitemid 34407487)
55. Monsuur AJ, Wijmenga C. Understanding the molecular basis of celiac disease: what genetic studies reveal. Ann Med 2006;38:578-91. (Pubitemid 46292017)
56. Spurkland A, Sollid LM, Polanco I, et al. HLA-DR and -DQ genotypes of celiac disease patients serologically typed to be non-DR3 or non-DR5/7. Hum Immunol 1992;35:188-92. (Pubitemid 23019554)
57. Trynka G, Hunt KA, Bockett NA, et al. Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat Genet 2011;43:1193-201.
58. Garner CP, Murray JA, Ding YC, et al. Replication of celiac disease UK genome-wide association study results in a US population. Hum Mol Genet 2009;18:4219-25.
59. Beitnes AC, Raki M, Lundin KE, et al. Density of CD163+ CD11c+ dendritic cells increases and CD103+ dendritic cells decreases in the coeliac lesion. Scand J Immunol 2011;74:186-94.
60. Raki M, Tollefsen S, Molberg O, et al. A unique dendritic cell subset accumulates in the celiac lesion and efficiently activates gluten-reactive T cells. Gastroenterology 2006;131:428-38. (Pubitemid 44142462)
61. Lundin KE, Scott H, Hansen T, et al. Gliadin-specific, HLA-DQ(alpha 1*0501, beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med 1993;178:187-96. (Pubitemid 23173254)
62. Lundin KE, Scott H, Fausa O, et al. T cells from the small intestinal mucosa of a DR4, DQ7/DR4, DQ8 celiac disease patient preferentially recognize gliadin when presented by DQ8. Hum Immunol 1994;41:285-91.
63. van de Wal Y, Kooy YM, van Veelen PA, et al. Small intestinal T cells of celiac disease patients recognize a natural pepsin fragment of gliadin. Proc Natl Acad Sci U S A 1998;95:10050-4. (Pubitemid 28415292)
64. Ellis HJ, Pollock EL, Engel W, et al. Investigation of the putative immunodominant T cell epitopes in coeliac disease. Gut 2003;52:212-7. (Pubitemid 36115061)
65. Camarca A, Anderson RP, Mamone G, et al. Intestinal T cell responses to gluten peptides are largely heterogeneous: implications for a peptide-based therapy in celiac disease. J Immunol 2009;182:4158-66.
66. Molberg O, McAdam SN, Korner R, et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease, in Nat Med 1998 Aug;4 (8):974.
67. Molberg O, McAdam SN, Korner R, et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease, in Nat Med 1998;4:713-7. (Pubitemid 28274673)
68. Tollefsen S, Arentz-Hansen H, Fleckenstein B, et al. HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease. J Clin Invest 2006;116: 2226-36. (Pubitemid 44162332)
69. Dieterich W, Ehnis T, Bauer M, et al. Identification of tissue transglutaminase as the autoantigen of celiac disease Nat Med 1997;3: 797-801. (Pubitemid 27298728)
70. Sulkanen S, Halttunen T, Laurila K, et al. Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease. Gastroenterology 1998;115:1322-8. (Pubitemid 28545980)
71. Di Niro R, Mesin L, Zheng NY, et al. High abundance of plasma cells secreting transglutaminase 2-specific IgA autoantibodies with limited somatic hypermutation in celiac disease intestinal lesions. Nat Med 2012;18:441-5.
72. Rashtak S, Ettore MW, Homburger HA, et al. Comparative usefulness of deamidated gliadin antibodies in the diagnosis of celiac disease. Clin Gastroenterol Hepatol 2008;6:426-32; quiz 370.
73. Tuire I, Marja-Leena L, Teea S, et al. Persistent duodenal intraepithelial lymphocytosis despite a long- Term strict gluten-free diet in celiac disease. Am J Gastroenterol 2012;107:1563-9.
74. Rostami K, Mulder CJ, van Overbeek FM, et al. Should relatives of coeliacs with mild clinical complaints undergo a small-bowel biopsy despite negative serology? Eur J Gastroenterol Hepatol 2000;12:51-5. (Pubitemid 30072104)
75. Hammer ST, Greenson JK. The clinical significance of duodenal lymphocytosis with normal villus architecture. Arch Pathol Lab Med 2013;137:1216-19.
76. Dahlbom I, Olsson M, Forooz NK, et al. Immunoglobulin G (IgG) anti- Tissue transglutaminase antibodies used as markers for IgA-deficient celiac disease patients. Clin Diagn Lab Immunol 2005;12:254-8. (Pubitemid 41094449)
77. Rashtak S, Ettore MW, Homburger HA, et al. Combination testing for antibodies in the diagnosis of coeliac disease: comparison of multiplex immunoassay and ELISA methods. Aliment Pharmacol Ther 2008;28:805-13.
78. Hill PG, Holmes GK. Coeliac disease: A biopsy is not always necessary for diagnosis. Aliment Pharmacol Ther 2008;27:572-7. (Pubitemid 351316782)
79. Egner W, Shrimpton A, Sargur R, et al. ESPGHAN guidance on coeliac disease 2012: multiples of ULN for decision making do not harmonise assay performance across centres. J Pediatr Gastroenterol Nutr 2012;55:733-5.
80. Lewis NR, Scott BB. Meta- Analysis: deamidated gliadin peptide antibody and tissue transglutaminase antibody compared as screening tests for coeliac disease. Aliment Pharmacol Ther 2010;31:73-81.
81. Raivio T, Kaukinen K, Nemes E, et al. Self transglutaminase-based rapid coeliac disease antibody detection by a lateral flow method. Aliment Pharmacol Ther 2006;24:147-54. (Pubitemid 43894015)
82. Korponay-Szabo IR, Szabados K, Pusztai J, et al. Population screening for coeliac disease in primary care by district nurses using a rapid antibody test: diagnostic accuracy and feasibility study. BMJ 2007;335:1244-7.
83. Collin P, Kaukinen K, Vogelsang H, et al. Antiendomysial and antihuman recombinant tissue transglutaminase antibodies in the diagnosis of coeliac disease: A biopsy-proven European multicentre study. Eur J Gastroenterol Hepatol 2005;17:85-91. (Pubitemid 40136613)
84. Hopper AD, Cross SS, Hurlstone DP, et al. Pre-endoscopy serological testing for coeliac disease: evaluation of a clinical decision tool. BMJ 2007;334:729.
85. Dickey W, Hughes DF, McMillan SA. Reliance on serum endomysial antibody testing underestimates the true prevalence of coeliac disease by one fifth. Scand J Gastroenterol 2000;35:181-3. (Pubitemid 30216588)
86. Murray JA, Herlein J, Mitros F, et al. Serologic testing for celiac disease in the United States: results of a multilaboratory comparison study. Clin Diagn Lab Immunol 2000;7:584-7. (Pubitemid 30463217)
87. Quine MA, Bell GD, McCloy RF, et al. Prospective audit of upper gastrointestinal endoscopy in two regions of England: safety, staffing, and sedation methods. Gut 1995;36:462-7.
88. Lebwohl B, Tennyson CA, Holub JL, et al. Sex and racial disparities in duodenal biopsy to evaluate for celiac disease. Gastrointest Endosc 2012;76:779-85.
89. Nachman F, Vazquez H, Gonzalez A, et al. Gastroesophageal reflux symptoms in patients with celiac disease and the effects of a gluten-free diet. Clin Gastroenterol Hepatol 2011;9:214-9.
90. Margaritte-Jeannin P, Babron MC, Bourgey M, et al. HLA-DQ relative risks for coeliac disease in European populations: A study of the European Genetics Cluster on Coeliac Disease. Tissue Antigens 2004;63:562-7. (Pubitemid 38748006)
91. Karell K, Louka AS, Moodie SJ, et al. HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease. Hum Immunol 2003;64:469-77. (Pubitemid 36373778)
92. Abadie V, Sollid LM, Barreiro LB, et al. Integration of genetic and immunological insights into a model of celiac disease pathogenesis. Annu Rev Immunol 2011;29:493-525.
93. Hadithi M, von Blomberg BM, Crusius JB, et al. Accuracy of serologic tests and HLA-DQ typing for diagnosing celiac disease. Ann Intern Med 2007;147: 294-302. (Pubitemid 351664556)
94. Polvi A, Arranz E, Fernandez- Arquero M, et al. HLA-DQ2-negative celiac disease in Finland and Spain. Hum Immunol 1998;59:169-75. (Pubitemid 28134571)
95. Rashtak S, Murray JA. Tailored testing for celiac disease. Ann Intern Med 2007;147:339-41. (Pubitemid 351664561)
96. Dickey W, Hughes D. Disappointing sensitivity of endoscopic markers for villous atrophy in a high-risk population: implications for celiac disease diagnosis during routine endoscopy. Am J Gastroenterol 2001;96:2126-8. (Pubitemid 32660908)
97. Olds G, McLoughlin R, O'Morian C, et al. Celiac disease for the endoscopist. Gastrointest Endosc 2002;56:407-15.
98. Oxentenko AS, Grisolano SW, Murray JA, et al. The insensitivity of endoscopic markers in celiac disease. Am J Gastroenterol 2002;97:933-8. (Pubitemid 34408251)
99. Cammarota G, Fedeli P, Gasbarrini A. Emerging technologies in upper gastrointestinal endoscopy and celiac disease. Nat Clin Pract Gastroenterol Hepatol 2009;6:47-56.
100. Serra S, Jani PA. An approach to duodenal biopsies. J Clin Pathol 2006;59:1133-50. (Pubitemid 44787133)
101. Lebwohl B, Kapel RC, Neugut AI, et al. Adherence to biopsy guidelines increases celiac disease diagnosis. Gastrointest Endosc 2011;74:103-9.
102. Horoldt BS, McAlindon ME, Stephenson TJ, et al. Making the diagnosis of coeliac disease: is there a role for push enteroscopy? Eur J Gastroenterol Hepatol 2004;16:1143-6. (Pubitemid 39488785)
103. Chang MS, Rubin M, Lewis SK, et al. Diagnosing celiac disease by video capsule endoscopy (VCE) when esophogastroduodenoscopy (EGD) and biopsy is unable to provide a diagnosis: A case series. BMC Gastroenterol 2012;12:90.
104. Elfstrom P, Granath F, Ekstrom Smedby K, et al. Risk of lymphoproliferative malignancy in relation to small intestinal histopathology among patients with celiac disease. J Natl Cancer Inst 2011;103:436-44.
105. Tennyson CA, Ciaccio EJ, Lewis SK. Video capsule endoscopy in celiac disease. Gastrointest Endosc Clin N Am 2012;22:747-58.
106. Atlas DS, Rubio- Tapia A, Van Dyke CT, et al. Capsule endoscopy in nonresponsive celiac disease. Gastrointest Endosc 2011;74:1315-22.
107. Kurppa K, Collin P, Viljamaa M, et al. Diagnosing mild enteropathy celiac disease: A randomized, controlled clinical study. Gastroenterology 2009;136:816-23.
108. Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). Gastroenterology 1992;102:330-54.
109. Oberhuber G, Granditsch G, Vogelsang H. The histopathology of coeliac disease: Time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol 1999;11:1185-94. (Pubitemid 30433773)
110. Corazza GR, Villanacci V. Coeliac disease. J Clin Pathol 2005;58:573-4. (Pubitemid 40814013)
111. Rostami K, Villanacci V. Microscopic enteritis: novel prospect in coeliac disease clinical and immuno-histogenesis. Evolution in diagnostic and treatment strategies. Dig Liver Dis 2009;41:245-52.
112. Walker MM, Murray JA, Ronkainen J, et al. Detection of celiac disease and lymphocytic enteropathy by parallel serology and histopathology in a population-based study. Gastroenterology 2010;139:112-19.
113. Villanacci V, Ceppa P, Tavani E, et al. Coeliac disease: The histology report. Dig Liver Dis 2011;43(Suppl 4):S385-95.
114. Arguelles-Grande C, Tennyson CA, Lewis SK, et al. Variability in small bowel histopathology reporting between different pathology practice settings: impact on the diagnosis of coeliac disease. J Clin Pathol 2012;65:242-7.
115. Ensari A. Gluten-sensitive enteropathy (celiac disease): controversies in diagnosis and classification. Arch Pathol Lab Med 2010;134:826-36.
116. Biagi F, Luinetti O, Campanella J, et al. Intraepithelial lymphocytes in the villous tip: do they indicate potential coeliac disease? J Clin Pathol 2004;57:835-9. (Pubitemid 39061432)
117. Jarvinen TT, Collin P, Rasmussen M, et al. Villous tip intraepithelial lymphocytes as markers of early-stage coeliac disease. Scand J Gastroenterol 2004;39: 428-33. (Pubitemid 38626621)
118. Corazza GR, Villanacci V, Zambelli C, et al. Comparison of the interobserver reproducibility with different histologic criteria used in celiac disease. Clin Gastroenterol Hepatol 2007;5:838-43. (Pubitemid 47031066)
119. Brown I, Mino-Kenudson M, Deshpande V, et al. Intraepithelial lymphocytosis in architecturally preserved proximal small intestinal mucosa: An increasing diagnostic problem with a wide differential diagnosis. Arch Pathol Lab Med 2006;130:1020-5. (Pubitemid 44061433)
120. Daum S, Cellier C, Mulder CJ. Refractory coeliac disease. Best Pract Res Clin Gastroenterol 2005;19:413-24. (Pubitemid 40753762)
121. Rubio- Tapia A, Murray JA. Classification and management of refractory coeliac disease. Gut 2010;59:547-57.
122. Aziz I, Evans KE, Hopper AD, et al. A prospective study into the aetiology of lymphocytic duodenosis. Aliment Pharmacol Ther 2010;32:1392-7.
123. Rubio- Tapia A, Herman ML, Ludvigsson JF, et al. Severe spruelike enteropathy associated with olmesartan. Mayo Clin Proc 2012;87:732-8.
124. Pallav K, Leffler DA, Tariq S, et al. Noncoeliac enteropathy: The differential diagnosis of villous atrophy in contemporary clinical practice. Aliment Pharmacol Ther 2012;35:380-90.
125. Koskinen O, Collin P, Lindfors K, et al. Usefulness of small-bowel mucosal transglutaminase-2 specific autoantibody deposits in the diagnosis and follow-up of celiac disease. J Clin Gastroenterol 2010;44:483-8.
126. Carroccio A, Iacono G, D'Amico D, et al. Production of anti-endomysial antibodies in cultured duodenal mucosa: usefulness in coeliac disease diagnosis. Scand J Gastroenterol 2002;37:32-8. (Pubitemid 34074731)
127. Carroccio A, Di Prima L, Pirrone G, et al. Anti- Transglutaminase antibody assay of the culture medium of intestinal biopsy specimens can improve the accuracy of celiac disease diagnosis. Clin Chem 2006;52:1175-80. (Pubitemid 43794432)
128. Banerjee R, Reddy DN. High-resolution narrow-band imaging can identify patchy atrophy in celiac disease: Targeted biopsy can increase diagnostic yield. Gastrointest Endosc 2009;69:984-5.
129. Siegel LM, Stevens PD, Lightdale CJ, et al. Combined magnification endoscopy with chromoendoscopy in the evaluation of patients with suspected malabsorption. Gastrointest Endosc 1997;46:226-30. (Pubitemid 27424343)
130. Leonard J, Haffenden G, Tucker W, et al. Gluten challenge in dermatitis herpetiformis. N Engl J Med 1983;308:816-19. (Pubitemid 13114678)
131. Seah PP, Fry L. Immunoglobulins in the skin in dermatitis herpetiformis and their relevance in diagnosis. Br J Dermatol 1975;92:157-66.
132. Fry L, Leonard JN, Swain F, et al. Long term follow-up of dermatitis herpetiformis with and without dietary gluten withdrawal. Br J Dermatol 1982;107:631-40. (Pubitemid 13238859)
133. Fry L, Seah PP, Harper PG, et al. The small intestine in dermatitis herpetiformis. J Clin Pathol 1974;27:817-24.
134. Lewis HM, Renaula TL, Garioch JJ, et al. Protective effect of gluten-free diet against development of lymphoma in dermatitis herpetiformis. Br J Dermatol 1996;135:363-7. (Pubitemid 26297828)
135. Hall NJ, Rubin G, Charnock A. Systematic review: Adherence to a gluten-free diet in adult patients with coeliac disease. Aliment Pharmacol Ther 2009;30:315-30.
136. Mayer M, Greco L, Troncone R, et al. Compliance of adolescents with coeliac disease with a gluten free diet. Gut 1991;32:881-5.
137. Bardella MT, Molteni N, Prampolini L, et al. Need for follow up in coeliac disease. Arch Dis Child 1994;70:211-3. (Pubitemid 24136408)
138. Ljungman G, Myrdal U. Compliance in teenagers with coeliac disease- A Swedish follow-up study. Acta Paediatr 1993;82:235-8. (Pubitemid 23107537)
139. Kolsteren MM, Koopman HM, Schalekamp G, et al. Health-related quality of life in children with celiac disease. J Pediatr 2001;138:593-5. (Pubitemid 32319739)
140. Pietzak MM. Follow-up of patients with celiac disease: Achieving compliance with treatment. Gastroenterology 2005;128:135-41.
141. Leffler DA, Edwards-George J, Dennis M, et al. Factors that influence adherence to a gluten-free diet in adults with celiac disease. Dig Dis Sci 2008;53:1573-81.
142. Dickey W, Ward M, Whittle CR, et al. Homocysteine and related B-vitamin status in coeliac disease: effects of gluten exclusion and histological recovery. Scand J Gastroenterol 2008;43:682-8. (Pubitemid 351868700)
143. Saibeni S, Lecchi A, Meucci G, et al. Prevalence of hyperhomocysteinemia in adult gluten-sensitive enteropathy at diagnosis: role of B12, folate, and genetics. Clin Gastroenterol Hepatol 2005;3:574-80. (Pubitemid 40824750)
144. Ciacci C, Spagnuolo G, Tortora R, et al. Urinary stone disease in adults with celiac disease: prevalence, incidence and urinary determinants. J Urol 2008;180:974-9.
145. Stenson WF, Newberry R, Lorenz R, et al. Increased prevalence of celiac disease and need for routine screening among patients with osteoporosis. Arch Intern Med 2005;165:393-9. (Pubitemid 40280193)
146. Elfstrom P, Montgomery SM, Kampe O, et al. Risk of thyroid disease in individuals with celiac disease. J Clin Endocrinol Metab 2008;93:3915-21.
147. Rapoport MJ, Bistritzer T, Vardi O, et al. Increased prevalence of diabetes-related autoantibodies in celiac disease. J Pediatr Gastroenterol Nutr 1996;23:524-7. (Pubitemid 27009098)
148. Ludvigsson JF, Ludvigsson J, Ekbom A, et al. Celiac disease and risk of subsequent Type 1 diabetes: A general population cohort study of children and adolescents. Diabetes Care 2006;29:2483-8. (Pubitemid 44912257)
149. Tursi A, Brandimarte G, Giorgetti GM. Lack of usefulness of anti- Transglutaminase antibodies in assessing histologic recovery after gluten-free diet in celiac disease. J Clin Gastroenterol 2003;37:387-91. (Pubitemid 37296167)
150. Vahedi K, Mascart F, Mary JY, et al. Reliability of antitransglutaminase antibodies as predictors of gluten-free diet compliance in adult celiac disease. Am J Gastroenterol 2003;98:1079-87. (Pubitemid 36733770)
151. Rubio- Tapia A, Rahim MW, See JA, et al. Mucosal recovery and mortality in adults with celiac disease after treatment with a gluten-free diet. Am J Gastroenterol 2010;105:1412-20.
152. Kaukinen K, Peraaho M, Lindfors K, et al. Persistent small bowel mucosal villous atrophy without symptoms in coeliac disease. Aliment Pharmacol Ther 2007;25:1237-45. (Pubitemid 46650299)
153. Dickey W, Hughes DF, McMillan SA. Patients with serum IgA endomysial antibodies and intact duodenal villi: clinical characteristics and management options. Scand J Gastroenterol 2005;40:1240-3. (Pubitemid 41510685)
154. Hopper AD, Hadjivassiliou M, Hurlstone DP, et al. What is the role of serologic testing in celiac disease? A prospective, biopsy-confirmed study with economic analysis. Clin Gastroenterol Hepatol 2008;6:314-20. (Pubitemid 351318379)
155. Dickey W, Hughes DF, McMillan SA. Disappearance of endomysial antibodies in treated celiac disease does not indicate histological recovery [in process citation]. Am J Gastroenterol 2000;95:712-4. (Pubitemid 30123907)
156. Lebwohl B, Murray JA, Rubio- Tapia A, et al. Predictors of persistent villous atrophy in coeliac disease: A population-based study. Aliment Pharmacol Ther 2014;39:488-95.
157. Hutchinson JM, West NP, Robins GG, et al. Long- Term histological follow-up of people with coeliac disease in a UK teaching hospital. QJM 2010;103:511-17.
158. Selby WS, Painter D, Collins A, et al. Persistent mucosal abnormalities in coeliac disease are not related to the ingestion of trace amounts of gluten. Scand J Gastroenterol 1999;34:909-14. (Pubitemid 29470571)
159. Ciacci C, Cirillo M, Cavallaro R, et al. Long- Term follow-up of celiac adults on gluten-free diet: prevalence and correlates of intestinal damage. Digestion 2002;66:178-85. (Pubitemid 36091849)
160. Lanzini A, Lanzarotto F, Villanacci V, et al. Complete recovery of intestinal mucosa occurs very rarely in adult coeliac patients despite adherence to gluten-free diet. Aliment Pharmacol Ther 2009;29:1299-308.
161. Wahab PJ, Meijer JW, Mulder CJ. Histologic follow-up of people with celiac disease on a gluten-free diet: slow and incomplete recovery. Am J Clin Pathol 2002;118:459-63. (Pubitemid 37046345)
162. Sainsbury A, Sanders DS, Ford AC. Prevalence of irritable bowel syndrome- Type symptoms in patients with celiac disease: A meta- Analysis. Clin Gastroenterol Hepatol 2013;11:359-651.
163. Ciacci C, Iavarone A, Mazzacca G, et al. Depressive symptoms in adult
164. Edwards George JB, Leffler DA, Dennis MD, et al. Psychological correlates of gluten-free diet adherence in adults with celiac disease. J Clin Gastroenterol 2009;43:301-6.
165. Leffler DA, Dennis M, Edwards George JB, et al. A simple validated gluten-free diet adherence survey for adults with celiac disease. Clin Gastroenterol Hepatol 2009;7:530-6.
166. Leffler DA, Dennis M, Edwards George JB, et al. A simple validated gluten-free diet adherence survey for adults with celiac disease. Clin Gastroenterol Hepatol 2009; 36 1-2.
167. Sainsbury K, Mullan B. Measuring beliefs about gluten free diet adherence in adult coeliac disease using the theory of planned behaviour. Appetite 2011;56:476-83.
168. Chauhan JC, Kumar P, Dutta AK, et al. Assessment of dietary compliance to gluten free diet and psychosocial problems in Indian children with celiac disease. Indian J Pediatr 2010;77:649-54.
169. Ciacci C, D'Agate C, De Rosa A, et al. Self-rated quality of life in celiac disease. Dig Dis Sci 2003;48:2216-20. (Pubitemid 38037313)
170. Hopman EG, Koopman HM, Wit JM, et al. Dietary compliance and health-related quality of life in patients with coeliac disease. Eur J Gastroenterol Hepatol 2009;21:1056-61.
171. Hogberg L, Grodzinsky E, Stenhammar L. Better dietary compliance in patients with coeliac disease diagnosed in early childhood. Scand J Gastroenterol 2003;38:751-4. (Pubitemid 36920497)
172. Biagi F, Bianchi PI, Marchese A, et al. A score that verifies adherence to a gluten-free diet: A cross-sectional, multicentre validation in real clinical life. Br J Nutr 2012;108:1884-8.
173. Charalampopoulos D, Panayiotou J, Chouliaras G, et al. Determinants of adherence to gluten-free diet in Greek children with coeliac disease: A cross-sectional study. Eur J Clin Nutr 2013;67:615-19.
174. Kurppa K, Lauronen O, Collin P, et al. Factors associated with dietary adherence in celiac disease: A nationwide study. Digestion 2012;86:309-14.
175. van Hees NJ, Van der Does W, Giltay EJ. Coeliac disease, diet adherence and depressive symptoms. J Psychosom Res 2013;74:155-60.
176. Lebwohl B, Granath F, Ekbom A, et al. Mucosal healing and mortality in coeliac disease. Aliment Pharmacol Ther 2013;37:332-9.
177. Lebwohl B, Granath F, Ekbom A, et al. Mucosal healing and risk for lymphoproliferative malignancy in celiac disease: A population-based cohort study. Ann Intern Med 2013;159:169-75.
178. Leffler D, Schuppan D, Pallav K, et al. Kinetics of the histological, serological and symptomatic responses to gluten challenge in adults with coeliac disease. Gut 2013;62:996-1004.
179. Herman ML, Rubio- Tapia A, Lahr BD, et al. Patients with celiac disease are not followed up adequately. Clin Gastroenterol Hepatol 2012;10:893-99.
180. Bebb JR, Lawson A, Knight T, et al. Long- Term follow-up of coeliac disease-what do coeliac patients want? Aliment Pharmacol Ther 2006;23:827-31. (Pubitemid 43344602)
181. Corazza GR, Di Sario A, Cecchetti L, et al. Bone mass and metabolism in patients with celiac disease. Gastroenterology 1995;109:122-8.
182. Corazza GR, Di Stefano M, Maurino E, et al. Bones in coeliac disease: diagnosis and treatment. Best Pract Res Clin Gastroenterol 2005;19:453-65. (Pubitemid 40753765)
183. McFarlane XA, Bhalla AK, Reeves DE, et al. Osteoporosis in treated adult coeliac disease. Gut 1995;36:710-14.
184. Passananti V, Santonicola A, Bucci C, et al. Bone mass in women with celiac disease: role of exercise and gluten-free diet. Dig Liver Dis 2012;44:379-83.
185. Capriles VD, Martini LA, Areas JA. Metabolic osteopathy in celiac disease: importance of a gluten-free diet. Nutr Rev 2009;67:599-606.
186. West J, Logan RF, Card TR, et al. Fracture risk in people with celiac disease: A population-based cohort study. Gastroenterology 2003;125:429-36. (Pubitemid 36929424)
187. Vestergaard P, Mosekilde L. Fracture risk in patients with celiac Disease, Crohn's disease, and ulcerative colitis: A nationwide follow-up study of 16, 416 patients in Denmark. Am J Epidemiol 2002;156:1-10. (Pubitemid 34680618)
188. Vasquez H, Mazure R, Gonzalez D, et al. Risk of fractures in celiac disease patients: A cross-sectional, case- control study. Am J Gastroenterol 2000;95:183-9. (Pubitemid 30041556)
189. Moreno ML, Vazquez H, Mazure R, et al. Stratification of bone fracture risk in patients with celiac disease. Clin Gastroenterol Hepatol 2004;2:127-34. (Pubitemid 38180466)
190. Davie MW, Gaywood I, George E, et al. Excess non-spine fractures in women over 50 years with celiac disease: A cross-sectional, questionnaire-based study. Osteoporos Int 2005;16:1150-5. (Pubitemid 41225102)
191. Ludvigsson JF, Michaelsson K, Ekbom A, et al. Coeliac disease and the risk of fractures- A general population-based cohort study. Aliment Pharmacol Ther 2007;25:273-85. (Pubitemid 46115397)
192. Jafri MR, Nordstrom CW, Murray JA, et al. Long- Term fracture risk in patients with celiac disease: A population-based study in Olmsted County, Minnesota. Dig Dis Sci 2007;53:964-71. (Pubitemid 351379839)
193. Corazza GR, Di Sario A, Cecchetti L, et al. Influence of pattern of clinical presentation and of gluten-free diet on bone mass and metabolism in adult coeliac disease. Bone 1996;18:525-30. (Pubitemid 26257872)
194. Bai JC, Gonzalez D, Mautalen C, et al. Long- Term effect of gluten restriction on bone mineral density of patients with coeliac disease. Aliment Pharmacol Ther 1997;11:157-64. (Pubitemid 27067348)
195. Valdimarsson T, Lofman O, Toss G, et al. Reversal of osteopenia with diet in adult coeliac disease. Gut 1996;38:322-7. (Pubitemid 26074313)
196. Ciacci C, Maurelli L, Klain M, et al. Effects of dietary treatment on bone mineral density in adults with celiac disease: factors predicting response. Am J Gastroenterol 1997;92:992-6. (Pubitemid 27237592)
197. Mautalen C, Gonzalez D, Mazure R, et al. Effect of treatment on bone mass, mineral metabolism, and body composition in untreated celiac disease patients. Am J Gastroenterol 1997;92:313-18. (Pubitemid 27076483)
198. Committee to Review Dietary Reference Intakes for Vitamin D and Calcium, Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Calcium and Vitamin D. Washington DC, 2010.
199. Malabanan AO, Holick MF. Vitamin D and bone health in postmenopausal women. J Womens Health (Larchmt) 2003;12:151-6. (Pubitemid 36546759)
200. Di Sabatino A, Rosado MM, Cazzola P, et al. Splenic hypofunction and the spectrum of autoimmune and malignant complications in celiac disease. Clin Gastroenterol Hepatol 2006;4:179-86. (Pubitemid 43199688)
201. Ludvigsson JF, Olen O, Bell M, et al. Coeliac disease and risk of sepsis. Gut 2008;57:1074-80.
202. Thomas HJ, Wotton CJ, Yeates D, et al. Pneumococcal infection in patients with coeliac disease. Eur J Gastroenterol Hepatol 2008;20:624-8.
203. Corazza GR, Frisoni M, Vaira D, et al. Effect of gluten-free diet on splenic hypofunction of adult coeliac disease. Gut 1983;24:228-30. (Pubitemid 13147738)
204. Primary Care Society for Gastroenterology UK. The Management of Adults with Coeliac Disease in Primary Care, 2006.
205. Marild K, Fredlund H, Ludvigsson JF. Increased risk of hospital admission for influenza in patients with celiac disease: A nationwide cohort study in Sweden. Am J Gastroenterol 2010;105:2465-73.
206. McKinley M, Leibowitz S, Bronzo R, et al. Appropriate response to pneumococcal vaccine in celiac sprue. J Clin Gastroenterol 1995;20:113-16.
207. Noh KW, Poland GA, Murray JA. Hepatitis B vaccine nonresponse and celiac disease. Am J Gastroenterol 2003;98:2289-92. (Pubitemid 37305372)
208. Zingone F, Morisco F, Zanetti A, et al. Long- Term antibody persistence and immune memory to hepatitis B virus in adult celiac patients vaccinated as adolescents. Vaccine 2011;29:1005-8.
209. Myleus A, Ivarsson A, Webb C, et al. Celiac disease revealed in 3% of Swedish 12-year-olds born during an epidemic. J Pediatr Gastroenterol Nutr 2009;49:170-6.
210. Vilppula A, Kaukinen K, Luostarinen L, et al. Increasing prevalence and high incidence of celiac disease in elderly people: A population-based study. BMC Gastroenterol 2009;9:49.
211. Katz KD, Rashtak S, Lahr BD, et al. Screening for celiac disease in a North American population: sequential serology and gastrointestinal symptoms. Am J Gastroenterol 2011;106:1333-9.
212. Collin P, Huhtala H, Virta L, et al. Diagnosis of celiac disease in clinical practice: physician's alertness to the condition essential. J Clin Gastroenterol 2007;41:152-6. (Pubitemid 46148656)
213. Murray JA, Watson T, Clearman B, et al. Effect of a gluten-free diet on gastrointestinal symptoms in celiac disease. Am J Clin Nutr 2004;79:669-73. (Pubitemid 41103913)
214. Holmes GK, Prior P, Lane MR, et al. Malignancy in coeliac disease-effect of a gluten free diet. Gut 1989;30:333-8. (Pubitemid 19091159)
215. Sanchez MI, Mohaidle A, Baistrocchi A, et al. Risk of fracture in celiac disease: gender, dietary compliance, or both? World J Gastroenterol 2011;17:3035-42.
216. Johnston SD, Rodgers C, Watson RG. Quality of life in screen-detected and typical coeliac disease and the effect of excluding dietary gluten. Eur J Gastroenterol Hepatol 2004;16:1281-6. (Pubitemid 39627526)
217. Whitaker JK, West J, Holmes GK, et al. Patient perceptions of the burden of coeliac disease and its treatment in the UK. Aliment Pharmacol Ther 2009;29:1131-6.
218. Ukkola A, Maki M, Kurppa K, et al. Patients' experiences and perceptions of living with coeliac disease-implications for optimizing care. J Gastrointestin Liver Dis 2012;21:17-22.
219. Nordyke K, Norstrom F, Lindholm L, et al. Health-related quality-of-life in children with coeliac disease, measured prior to receiving their diagnosis through screening. J Med Screen 2011;18:187-92.
220. Johnston SD, Watson RG, McMillan SA, et al. Coeliac disease detected by screening is not silent-simply unrecognized. QJM 1998;91:853-60. (Pubitemid 29027072)
221. Rubio- Tapia A, Kyle RA, Kaplan EL, et al. Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology 2009;137:88-93.
222. Ukkola A, Maki M, Kurppa K, et al. Diet improves perception of health and well-being in symptomatic, but not asymptomatic, patients with celiac disease. Clin Gastroenterol Hepatol 2011;9:118-23.
223. Nachman F, Maurino E, Vazquez H, et al. Quality of life in celiac disease patients: prospective analysis on the importance of clinical severity at diagnosis and the impact of treatment. Dig Liver Dis 2009;41:15-25.
224. Mustalahti K, Lohiniemi S, Collin P, et al. Gluten-free diet and quality of life in patients with screen-detected celiac disease. Eff Clin Pract 2002;5:105-13.
225. van Koppen EJ, Schweizer JJ, Csizmadia CG, et al. Long- Term health and quality-of-life consequences of mass screening for childhood celiac disease: A 10-year follow-up study. Pediatrics 2009;123:582-8.
226. Hin H, Bird G, Fisher P, et al. Coeliac disease in primary care: case finding study. BMJ 1999;318:164-7. (Pubitemid 29192607)
227. Marild K, Stephansson O, Grahnquist L, et al. Down syndrome is associated with elevated risk of celiac disease: A nationwide case-control study. J Pediatr 2013;163:237-42.
228. Vestergaard P, Mosekilde L. Fractures in patients with hyperthyroidism and hypothyroidism: A nationwide follow-up study in 16, 249 patients. Thyroid 2002;12:411-19. (Pubitemid 34602601)
229. Halfdanarson TR, Litzow MR, Murray JA. Hematological manifestations of celiac disease. Blood 2006;109:412-21.
230. Ford AC, Chey WD, Talley NJ, et al. Yield of diagnostic tests for celiac disease in individuals with symptoms suggestive of irritable bowel syndrome: systematic review and meta- Analysis. Arch Intern Med 2009;169:651-8.
231. Green PHR, Stavropoulos SN, Panagi SG, et al. Characteristics of adult celiac disease in the USA: results of a national survey. Am J Gastroenterol 2001;96:126-31. (Pubitemid 32104819)
232. Ciacci C, Iavarone A, Siniscalchi M, et al. Psychological dimensions of celiac disease: Toward an integrated approach. Dig Dis Sci 2002;47:2082-7. (Pubitemid 35024826)
233. de Rosa A, Troncone A, Vacca M, et al. Characteristics and quality of illness behaviour in celiac disease. Psychosomatics 2004;45:336-42. (Pubitemid 38823609)
234. Hauser W, Gold J, Stein J, et al. Health-related quality of life in adult coeliac disease in Germany: results of a national survey. Eur J Gastroenterol Hepatol 2006;18:747-54.
235. Vilppula A, Kaukinen K, Luostarinen L, et al. Clinical benefit of gluten-free diet in screen-detected older celiac disease patients. BMC Gastroenterol 2011;11:136.
236. Smith DF, Gerdes LU. Meta- Analysis on anxiety and depression in adult celiac disease. Acta Psychiatr Scand 2012;125:189-93.
237. Sanders DS, Patel D, Stephenson TJ, et al. A primary care cross-sectional study of undiagnosed adult coeliac disease. Eur J Gastroenterol Hepatol 2003;15:407-13. (Pubitemid 36521040)
238. Platt SG, Kasarda DD. Separation and characterization of -gliadin fractions. Biochim Biophys Acta 1971;243:407-15.
239. Janatuinen EK, Pikkarainen PH, Kemppainen TA, et al. A comparison of diets with and without oats in adults with celiac disease. N Engl J Med 1995;333:1033-7.
240. Janatuinen EK, Kemppainen TA, Pikkarainen PH, et al. Lack of cellular and humoral immunological responses to oats in adults with coeliac disease. Gut 2000;46:327-31. (Pubitemid 30313382)
241. Sadiq Butt M, Tahir-Nadeem M, Khan MK, et al. Oat: unique among the cereals. Eur J Nutr 2008;47:68-79.
242. Comino I, Real A, de Lorenzo L, et al. Diversity in oat potential immunogenicity: basis for the selection of oat varieties with no toxicity in coeliac disease. Gut 2011;60:915-22.
243. Lundin KE, Nilsen EM, Scott HG, et al. Oats induced villous atrophy in coeliac disease. Gut 2003;52:1649-52. (Pubitemid 37363452)
244. Arentz-Hansen H, Fleckenstein B, Molberg O, et al. The molecular basis for oat intolerance in patients with celiac disease. PloS Med 2004;1:1.
245. Case S. The gluten-free diet: how to provide effective education and resources. Gastroenterology 2005;128:128-34.
246. Wild D, Robins GG, Burley VJ, et al. Evidence of high sugar intake, and low fibre and mineral intake, in the gluten-free diet. Aliment Pharmacol Ther 2010;32:573-81.
247. Ukkola A, Maki M, Kurppa K, et al. Changes in body mass index on a gluten-free diet in coeliac disease: A nationwide study. Eur J Intern Med 2012;23:384-8.
248. Nelson M, Mendoza N, McGough N. A survey of provision of dietetic services for coeliac disease in the UK. J Hum Nutr Diet 2007;20:403-11. (Pubitemid 47382297)
249. Leffler D, Vanga R, Mukherjee R. Mild enteropathy celiac disease: A wolf in sheep's clothing? Clin Gastroenterol Hepatol 2013;11:259-61.
250. Akobeng AK, Thomas AG. Systematic review: Tolerable amount of gluten for people with coeliac disease. Aliment Pharmacol Ther 2008;27:1044-52. (Pubitemid 351614885)
251. Hischenhuber C, Crevel R, Jarry B, et al. Review article: safe amounts of gluten for patients with wheat allergy or coeliac disease. Aliment Pharmacol Ther 2006;23:559-75.
252. Ventura A, Magazzu G, Greco L. Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. SIGEP Study Group for Autoimmune Disorders in Celiac Disease. Gastroenterology 1999;117:297-303. (Pubitemid 29352936)
253. Corrao G, Corazza GR, Bagnardi V, et al. Mortality in patients with coeliac disease and their relatives: A cohort study. Lancet 2001;358:356-61. (Pubitemid 32739095)
254. Khashan AS, Henriksen TB, Mortensen PB, et al. The impact of maternal celiac disease on birthweight and preterm birth: A Danish population-based cohort study. Hum Reprod 2010;25:528-34.
255. Silano M, Volta U, Vincenzi AD, et al. Effect of a gluten-free diet on the risk of enteropathy- Associated T-cell lymphoma in celiac disease. Dig Dis Sci 2008;53:972-6. (Pubitemid 351379816)
256. Green PH, Fleischauer AT, Bhagat G, et al. Risk of malignancy in patients with celiac disease. Am J Med 2003;115:191-5. (Pubitemid 37338143)
257. Olen O, Askling J, Ludvigsson JF, et al. Coeliac disease characteristics, compliance to a gluten free diet and risk of lymphoma by subtype. Dig Liver Dis 2011;43:862-8.
258. Karajeh MA, Hurlstone DP, Patel TM, et al. Chefs' knowledge of coeliac disease (compared to the public): A questionnaire survey from the United Kingdom. Clin Nutr 2005;24:206-10. (Pubitemid 40392803)
259. Singh J, Whelan K. Limited availability and higher cost of gluten-free foods. J Hum Nutr Diet 2011;24:479-86.
260. Lee AR, Ng DL, Zivin J, et al. Economic burden of a gluten-free diet. J Hum Nutr Diet 2007;20:423-30. (Pubitemid 47382299)
261. Drossman DA, Brandt LJ, Sears C, et al. A preliminary study of patients' concerns related to GI endoscopy. Am J Gastroenterol 1996;91:287-91. (Pubitemid 26067336)
262. Ford S, Howard R, Oyebode J. Psychosocial aspects of coeliac disease: A cross-sectional survey of a UK population. Br J Health Psychol 2012;17:743-57.
263. Lee AR, Ng DL, Diamond B, et al. Living with coeliac disease: survey results from the USA. J Hum Nutr Diet 2012;25:233-8.
264. Bystrom IM, Hollen E, Falth-Magnusson K, et al. Health-related quality of life in children and adolescents with celiac disease: from the perspectives of children and parents. Gastroenterol Res Pract 2012;2012:986475.
265. Nachman F, del Campo MP, Gonzalez A, et al. Long- Term deterioration of quality of life in adult patients with celiac disease is associated with treatment noncompliance. Dig Liver Dis 2010;42:685-91.
266. Long KH, Rubio- Tapia A, Wagie AE, et al. The economics of coeliac disease: A population-based study. Aliment Pharmacol Ther 2010;32:261-9.
267. Leffler DA, Dennis M, Hyett B, et al. Etiologies and predictors of diagnosis in nonresponsive celiac disease. Clin Gastroenterol Hepatol 2007;5:445-50. (Pubitemid 46575362)
268. Abdulkarim AS, Burgart LJ, See J, et al. Etiology of nonresponsive celiac disease: results of a systematic approach. Am J Gastroenterol 2002;97:2016-21.
269. Biagi F, Corazza GR. Defining gluten refractory enteropathy. Eur J Gastroenterol Hepatol 2001;13:561-5. (Pubitemid 32466260)
270. Fine KD, Meyer RL, Lee EL. The prevalence and causes of chronic diarrhea in patients with celiac sprue treated with a gluten-free diet. Gastroenterology 1997;112:1830-8. (Pubitemid 27240767)
271. Dewar DH, Donnelly SC, McLaughlin SD, et al. Celiac disease: management of persistent symptoms in patients on a gluten-free diet. World J Gastroenterol 2012;18:1348-56.
272. Dickey W. Colon neoplasia co-existing with coeliac disease in older patients: coincidental, probably; important, certainly. Scand J Gastroenterol 2002;37:1054-6.
273. Leeds JS, Hopper AD, Hurlstone DP, et al. Is exocrine pancreatic insufficiency in adult coeliac disease a cause of persisting symptoms? Aliment Pharmacol Ther 2007;25:265-71. (Pubitemid 46115396)
274. Olesen M, Eriksson S, Bohr J, et al. Microscopic colitis: A common diarrhoeal disease. An epidemiological study in Orebro, Sweden, 1993-1998. Gut 2004;53:346-50. (Pubitemid 38241327)
275. Cellier C, Delabesse E, Helmer C, et al. Refractory sprue, coeliac disease, and enteropathy- Associated T-cell lymphoma. French Coeliac Disease Study Group. Lancet 2000;356:203-8.
276. Rubio- Tapia A, Kelly DG, Lahr BD, et al. Clinical staging and survival in refractory celiac disease: A single center experience. Gastroenterology 2009;136:99-107; quiz 352-3.
277. Malamut G, Afchain P, Verkarre V, et al. Presentation and long- Term follow-up of refractory celiac disease: comparison of type I with type II. Gastroenterology 2009;136:81-90.
278. Biagi F, Lorenzini P, Corazza GR. Literature review on the clinical relationship between ulcerative jejunoileitis, coeliac disease, and enteropathy- Associated T-cell. Scand J Gastroenterol 2000;35:785-90.
279. Goerres MS, Meijer JW, Wahab PJ, et al. Azathioprine and prednisone combination therapy in refractory coeliac disease. Aliment Pharmacol Ther 2003;18:487-94. (Pubitemid 37152289)
280. Maurino E, Niveloni S, Chernavsky A, et al. Azathioprine in refractory sprue: results from a prospective, open-label study. Am J Gastroenterol 2002;97:2595-602.
281. Gale J, Simmonds PD, Mead GM, et al. Enteropathy- Type intestinal T-cell lymphoma: clinical features and treatment of 31 patients in a single center. J Clin Oncol 2000;18:795-803. (Pubitemid 30106610)
282. Domizio P, Owen RA, Shepherd NA, et al. Primary lymphoma of the small intestine. A clinicopathological study of 119 cases. Am J Surg Pathol 1993;17:429-42. (Pubitemid 23121773)
283. Deleeuw RJ, Zettl A, Klinker E, et al. Whole-genome analysis and HLA genotyping of enteropathy- Type T-cell lymphoma reveals 2 distinct lymphoma subtypes. Gastroenterology 2007;132:1902-11. (Pubitemid 46677947)
284. Kane EV, Newton R, Roman E. Non-Hodgkin lymphoma and gluten-sensitive enteropathy: estimate of risk using meta- Analyses. Cancer Causes Control 2011;22:1435-44.
285. Zettl A, de Leeuw R, Haralambieva E, et al. Enteropathy- Type T-cell lymphoma. Am J Clin Pathol 2007;127:701-6.
286. Smedby KE, Akerman M, Hildebrand H, et al. Malignant lymphomas in coeliac disease: evidence of increased risks for lymphoma types other than enteropathy- Type T cell lymphoma. Gut 2005;54:54-9. (Pubitemid 40007218)
287. Leslie LA, Lebwohl B, Neugut AI, et al. Incidence of lymphoproliferative disorders in patients with celiac disease. Am J Hematol 2012;87:754-9.
288. Olen O, Askling J, Ludvigsson JF, et al. Coeliac disease characteristics, compliance to a gluten free diet and risk of lymphoma by subtype. Dig Liver Dis 2011;43:862-8.
289. Moertel CG, Hargraves MM. Coexistence of adenocarcinoma of the jejunum and nontropical sprue. JAMA 1961;176:612-4.
290. Card TR, West J, Holmes GK. Risk of malignancy in diagnosed coeliac disease: A 24-year prospective, population-based, cohort study. Aliment Pharmacol Ther 2004;20:769-75. (Pubitemid 39319232)
291. Elfstrom P, Granath F, Ye W, et al. Low risk of gastrointestinal cancer among patients with celiac disease, inflammation, or latent celiac disease. Clin Gastroenterol Hepatol 2012;10:30-6.
292. McSorley HJ, Gaze S, Daveson J, et al. Suppression of inflammatory immune responses in celiac disease by experimental hookworm infection. PloS ONE 2011;6:e24092.
293. Daveson AJ, Jones DM, Gaze S, et al. Effect of hookworm infection on wheat challenge in celiac disease- A randomised double-blinded placebo controlled trial. PloS ONE 2011;6:e17366.
294. Brenchley R, Spannagl M, Pfeifer M, et al. Analysis of the bread wheat genome using whole-genome shotgun sequencing. Nature 2012;491:705-10.
295. Gil-Humanes J, Piston F, Tollefsen S, et al. Effective shutdown in the expression of celiac disease-related wheat gliadin T-cell epitopes by RNA interference. Proc Natl Acad Sci U S A 2010;107:17023-8.
296. Matysiak-Budnik T, Candalh C, Cellier C, et al. Limited efficiency of prolyl-endopeptidase in the detoxification of gliadin peptides in celiac disease. Gastroenterology 2005;129:786-96. (Pubitemid 41242671)
297. Mitea C, Havenaar R, Drijfhout JW, et al. Efficient degradation of gluten by a prolyl endoprotease in a gastrointestinal model: implications for coeliac disease. Gut 2008;57:25-32.
298. Pyle GG, Paaso B, Anderson BE, et al. Effect of pretreatment of food gluten with prolyl endopeptidase on gluten-induced malabsorption in celiac sprue. Clin Gastroenterol Hepatol 2005;3:687-94. (Pubitemid 40984730)
299. Gass J, Bethune MT, Siegel M, et al. Combination enzyme therapy for gastric digestion of dietary gluten in patients with celiac sprue. Gastroenterology 2007;133:472-80. (Pubitemid 47187353)
300. Tye-Din JA, Stewart JA, Dromey JA, et al. Comprehensive, quantitative mapping of T cell epitopes in gluten in celiac disease. Sci Transl Med 2010;2:41-51.
301. Gopalakrishnan S, Durai M, Kitchens K, et al. Larazotide acetate regulates epithelial tight junctions in vitro and in vivo. Peptides 2012;35:86-94.
302. Paterson BM, Lammers KM, Arrieta MC, et al. The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT-1001 in coeliac disease subjects: A proof of concept study. Aliment Pharmacol Ther 2007;26:757-66. (Pubitemid 47246202)
303. Leffler DA, Kelly CP, Abdallah HZ, et al. A randomized, double-blind study of larazotide acetate to prevent the activation of celiac disease during gluten challenge. Am J Gastroenterol 2012;107:1554-62.
304. Hoffmann K, Alminger M, Andlid T, et al. Blocking peptides decrease tissue transglutaminase processing of gliadin in vitro. J Agric Food Chem 2009;57:10150-5.
305. Stoven S, Murray JA, Marietta E. Celiac disease: Advances in treatment via gluten modification. Clin Gastroenterol Hepatol 2012;10:859-62.
306. van der Windt DA, Jellema P, Mulder CJ, et al. Diagnostic testing for celiac disease among patients with abdominal symptoms: A systematic review. JAMA 2010;303:1738-46.
307. Mooney PD, Evans KE, Singh S, et al. Treatment failure in coeliac disease: A practical guide to investigation and treatment of non-responsive and refractory coeliac disease. J Gastrointestin Liver Dis 2012;21:197-203.